Clinical references and scope
Psoriasis
Diagnostic overview
Psoriasis only; not all skin disorders.
NIAMS: Public diagnostic overview
Scope of this clinical reference
- Full subtype/differential coverage, severity instrument validation and other skin conditions remain open.
Professional assessments
Evidence and examination topics
- Diagnosis and history: Records identifying the current diagnosis, onset, course, and relevant medical history.
- Treatment and medications: Treatment records, medication history, procedures, and therapy documentation.
- Diagnostic tests and measurements: Condition-relevant tests, imaging, laboratory results, and objective measurements.
- Symptoms and episodes: Records or statements documenting symptoms, severity, frequency, duration, and episodes.
- Clinical findings: Examination findings that are relevant to the public DBQ or rating criteria.
- Scars and residual findings: Records describing relevant scars and residual physical findings.
- Functional impact: Medical and lay evidence describing work and daily-activity effects.
- Service connection evidence: Evidence addressing an in-service event, exposure, disease, injury, continuity, or a secondary relationship.
What the VA questionnaire covers
Official Skin Diseases questionnaire ↗
Source version 24_1; updated 2024-07-15. Use the original questionnaire for the complete wording and exceptions.
- diagnosis · source pages 2
- medical history · source pages 3
- treatment · source pages 3, 4, 5, 6
- physical exam · source pages 6, 7
- specific skin conditions · source pages 7, 8, 9
- tumors and neoplasms · source pages 9, 10
- scarring and disfigurement · source pages 10
- other pertinent physical findings, complications, conditions, signs and/or symptoms · source pages 11
- functional impact · source pages 11
- remarks · source pages 12
Full rating rules and tables
Understand service-connection and nexus evidence →Related rating guides
Shared reference edition 1.2.4 · source check 2026-11-06. Coverage is stated for each framework and is distinct from clinical review. Rating-source snapshot: 2026-06-30.